According to the announcement by IDT INT'L (00167) on its proactive actions taken by the board of directors to meet all resumption guidance, on September 3, 2024, the company submitted a resumption application to the Stock Exchange, demonstrating the company's compliance with the resumption guidance. Subsequently, the company has submitted additional supplementary information to the Stock Exchange regarding the resumption application. As of the date of this announcement, the resumption application is still under review by the Stock Exchange, and the resumption of trading in the company's shares is subject to the approval and confirmation by the Stock Exchange.

As previously disclosed, the group has resumed selling electronic products under the 'Oregon Scientific' brand, and has developed and started operating multiple online retail platforms to increase market awareness of the 'Oregon Scientific' brand and promote and showcase products to the retail market.

As of the date of this announcement, the confirmed order of 70 million Hong Kong dollars scheduled for delivery in the third quarter of 2024 has been completed. Based on the unaudited management accounts for the third quarter of 2024, the unaudited revenue of the group (primarily from the sale of electronic products) is approximately 76 million Hong Kong dollars. The group has also received orders totaling approximately 40 million Hong Kong dollars expected to be completed and delivered in the fourth quarter of 2024.

The group will continue to periodically review its existing business and strive to improve the group's business operations and financial condition. The business strategy of the group is to actively seek potential business and investment opportunities to expand revenue sources.

Additionally, the company continues to actively communicate with its creditors to reach a negotiated solution to address the company's working capital issues and settle the company's debts. Trading in the company's shares remains suspended.